Truist raised the firm’s price target on Amphenol (APH) to $147 from $126 and keeps a Buy rating on the shares after its Q3 earnings beat. The stock’s run continues to look sensible as the firm sees margin upside owing to a combo of accelerated sales growth and end market mix, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APH:
- Amphenol price target raised to $152 from $145 at UBS
- Amphenol price target raised to $163 from $150 at BofA
- Amphenol’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
- Amphenol price target raised to $160 from $145 at Citi
- Amphenol price target raised to $154 from $139 at Goldman Sachs